secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspire Biopharma Holdings, Inc. (ASBP)
CIK:        0001847345
Form:       8-K
Filed at:   2022-05-19T23:59:59+00:00
Accession:  0001104659-22-062870
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

PowerUp Acquisition Corp. appoints Kyle Campbell as independent Class III director
--------------------------------------------------------------------------------

- Kyle Campbell appointed as Class III director effective May 16, 2022.
- Board determined Campbell is independent under Nasdaq and SEC rules; joins Audit Committee.
- Campbell is senior analyst at Greenhaven Road Capital and former CFO of a family office.
- No family relationships or transactions with the company exist.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847345/000110465922062870/0001104659-22-062870-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847345/000110465922062870/tm2215972d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-062870

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer